OPPM
Opus Point Partners Management’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-93,805
| Closed | -$5.37M | – | 48 |
|
|
2018
Q2 | $5.37M | Sell |
93,805
-93,805
| -50% | -$5.37M | 11.64% | 2 |
|
|
2018
Q1 | $10.3M | Buy |
187,610
+57,110
| +44% | +$3.14M | 20.26% | 1 |
|
|
2017
Q4 | $7.32M | Hold |
130,500
| – | – | 6.33% | 1 |
|
|
2017
Q3 | $7.99M | Hold |
130,500
| – | – | 7.17% | 1 |
|
|
2017
Q2 | $6.97M | Buy |
130,500
+45,500
| +54% | +$2.43M | 6.38% | 1 |
|
|
2017
Q1 | $4.1M | Hold |
85,000
| – | – | 3.04% | 10 |
|
|
2016
Q4 | $3.39M | Hold |
85,000
| – | – | 2.7% | 10 |
|
|
2016
Q3 | $4.12M | Buy |
+85,000
| New | +$4.12M | 2.31% | 4 |
|
|
2016
Q2 | – | Sell |
-64,462
| Closed | -$2.64M | – | 45 |
|
|
2016
Q1 | $2.64M | Buy |
64,462
+49,543
| +332% | +$2.03M | 2.04% | 21 |
|
|
2015
Q4 | $1.07M | Sell |
14,919
-17,798
| -54% | -$1.27M | 0.7% | 39 |
|
|
2015
Q3 | $1.91M | Sell |
32,717
-20,851
| -39% | -$1.21M | 1.05% | 25 |
|
|
2015
Q2 | $4.84M | Buy |
53,568
+35,784
| +201% | +$3.23M | 3.83% | 4 |
|
|
2015
Q1 | $2.82M | Sell |
17,784
-20,400
| -53% | -$3.23M | 2.36% | 24 |
|
|
2014
Q4 | $4.79M | Buy |
+38,184
| New | +$4.79M | 4.74% | 1 |
|